1. Home
  2. KVYO vs STVN Comparison

KVYO vs STVN Comparison

Compare KVYO & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$32.01

Market Cap

8.9B

Sector

N/A

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$20.35

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
STVN
Founded
2012
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Containers/Packaging
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
7.4B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
KVYO
STVN
Price
$32.01
$20.35
Analyst Decision
Strong Buy
Buy
Analyst Count
24
4
Target Price
$43.54
$25.38
AVG Volume (30 Days)
2.2M
281.8K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
0.31%
EPS Growth
N/A
19.61
EPS
N/A
0.60
Revenue
$1,153,988,000.00
$1,373,219,524.00
Revenue This Year
$32.38
$8.42
Revenue Next Year
$21.60
$9.52
P/E Ratio
N/A
$34.35
Revenue Growth
32.81
6.97
52 Week Low
$23.44
$17.81
52 Week High
$49.55
$28.00

Technical Indicators

Market Signals
Indicator
KVYO
STVN
Relative Strength Index (RSI) 66.13 39.35
Support Level $28.55 $20.50
Resistance Level $30.35 $21.54
Average True Range (ATR) 1.14 1.06
MACD 0.20 -0.06
Stochastic Oscillator 94.59 11.29

Price Performance

Historical Comparison
KVYO
STVN

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: